Companies Facing Changing Consumption Patterns due to Expensive Drugs

Companies are facing challenges due to changing consumption patterns caused by drugs. The expensive medications are impacting sales and leading to shifts in customer behavior. Despite potential blame on AI, these issues are affecting various industries. For example, the textbook company attributed their troubles to AI last quarter. However, companies in the food industry have yet to report a collapse in sales due to AI. The high cost of drugs like Ozempic and Magobi, priced between $800 to $1,200 per month, is also a significant factor. Despite the potential for competition, Lily is expected to receive approval for a weight loss drug, leading to a duopoly in the market for a few years.